Chemoinformaics analysis of CIS-12,13-EPOXYOCTADEC-TRANS-9-CIS-ACID
Molecular Weight | 292.419 | nRot | 11 |
Heavy Atom Molecular Weight | 264.195 | nRig | 8 |
Exact Molecular Weight | 292.204 | nRing | 1 |
Solubility: LogS | -4.364 | nHRing | 0 |
Solubility: LogP | 4.798 | No. of Aliphatic Rings | 1 |
Acid Count | 1 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 49 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 0 |
nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 18 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 51.1362 |
nHD | 1 | BPOL | 29.8258 |
QED | 0.439 |
Synth | 2.813 |
Natural Product Likeliness | 1.594 |
NR-PPAR-gamma | 0.968 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.17 |
Pgp-sub | 0.001 |
HIA | 0.022 |
CACO-2 | -4.973 |
MDCK | 0.000025 |
BBB | 0.053 |
PPB | 0.964842 |
VDSS | 0.515 |
FU | 0.0078088 |
CYP1A2-inh | 0.086 |
CYP1A2-sub | 0.393 |
CYP2c19-inh | 0.064 |
CYP2c19-sub | 0.068 |
CYP2c9-inh | 0.203 |
CYP2c9-sub | 0.965 |
CYP2d6-inh | 0.046 |
CYP2d6-sub | 0.207 |
CYP3a4-inh | 0.044 |
CYP3a4-sub | 0.075 |
CL | 2.007 |
T12 | 0.852 |
hERG | 0.007 |
Ames | 0.005 |
ROA | 0.009 |
SkinSen | 0.91 |
Carcinogencity | 0.512 |
EI | 0.196 |
Respiratory | 0.236 |
NR-Aromatase | 0.088 |
Antiviral | Yes |
Prediction | 0.680147 |